Alogliptin Wins FDA Go-Ahead for Type 2 Diabetes
(MedPage Today) -- SILVER SPRING, Md. -- After a long delay, the FDA approved the oral drug alogliptin (Nesina) for treatment of adults with type 2 diabetes, as well as two products combining alogliptin with other antidiabetic drugs.
Tags:
Alogliptin Wins FDA Go-Ahead for Type 2 Diabetes,
Diabetes Latest News